Login

Securities offered through IFP Securities, LLC, while Starbucks' CEO discusses business strategy in a separate segment. 00:10:00

Share On Facebook Share On Twitter

William Hamm, CFA, CFP®, CLU. Chief Executive Officer 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Machine Learning Model for Hypertension Management - Dr. Lee Herzog
00:10:00
CEO discusses expansion of cancer biomarker technology research program and future commercialization plans with University of York collaboration | Allan Syms,CEO, Cizzle Biotechnology Holdings PLC.
00:10:00
Strategies for Managing Health Care Expenses in Retirement | David W. Shotwell, CEO, Shotwell Rutter Baer.
00:10:00
A Pillar of Australia's Financial Sector and Community Leadership|Chairman ,BWP Trust
00:10:00
Chairman and CEO John W. Casella discusses career paths, CDL training, and the multifaceted rewards of working at Casella Waste Systems.
00:10:00
Stephen Schwarzman on the Fitch Downgrade and U.S. Political Landscape | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Daniel Dines of UiPath presents 10 AI innovations poised to change lives at UiPath FORWARD VI 2023.
00:10:00
AXA CEO Thomas Buberl Discusses Emerging Virus Threats and Insurance Industry Impacts
00:10:00
Thesis Gold and Benchmark Metals: A Transformative Merger for Precious Metals Development
00:10:00
Robert Strzelecki on TenderHut's Main Floor Transition and Startups' Market Challenges | Robert Strzelecki, CEO , TenderHut SA.
00:10:00
Q4 2023 Market Update: Navigating Economic Challenges and Investment Opportunities
00:10:00
Fortitude Gold's Projects and Future Plans

© 2017 - Neuhu+